BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26562558)

  • 1. Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010.
    Boyar Cetinkaya R; Aagnes B; Thiis-Evensen E; Tretli S; Bergestuen DS; Hansen S
    Neuroendocrinology; 2017; 104(1):1-10. PubMed ID: 26562558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival in neuroendocrine neoplasms; A report from a large Norwegian population-based study.
    Boyar Cetinkaya R; Aagnes B; Myklebust TÅ; Thiis-Evensen E
    Int J Cancer; 2018 Mar; 142(6):1139-1147. PubMed ID: 29082524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria.
    Sandvik OM; Søreide K; Gudlaugsson E; Kvaløy JT; Søreide JA
    Br J Surg; 2016 Feb; 103(3):226-32. PubMed ID: 26511392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patients.
    Nikou GC; Pazaitou-Panayiotou K; Dimitroulopoulos D; Alexandrakis G; Papakostas P; Vaslamatzis M; Kaldrymidis P; Markussis V; Koumarianou A;
    BMC Endocr Disord; 2016 Feb; 16():8. PubMed ID: 26872616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and prevalence of neuroendocrine neoplasms in Norway 1993-2021.
    Thiis-Evensen E; Boyar Cetinkaya R
    J Neuroendocrinol; 2023 Apr; 35(4):e13264. PubMed ID: 36988112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic trends and survival of early-onset gastroenteropancreatic neuroendocrine neoplasms.
    Yao H; Hu G; Jiang C; Fan M; Yuan L; Shi H; Lin R
    Front Endocrinol (Lausanne); 2023; 14():1241724. PubMed ID: 37701903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Retrospective Cohort Study of Histology-Proven Neuroendocrine Neoplasms in the Italian Area of Udine.
    Valent F; Tullio A; Kara E; Cipri C; Sciannimanico SM; Vescini F; Grimaldi F
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):448-457. PubMed ID: 32660412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological characteristics of neuroendocrine neoplasms in Beijing: a population-based retrospective study.
    Chi Y; Liu S; Zhang J; Li H; Yang L; Zhang X; Li H; Li Q; Wang N; Lu M; Zhuo M
    BMC Public Health; 2024 May; 24(1):1396. PubMed ID: 38789981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Real-World, Population-Based Study for the Incidence and Outcomes of Neuroendocrine Neoplasms of Unknown Primary.
    Abdel-Rahman O
    Neuroendocrinology; 2021; 111(9):876-882. PubMed ID: 32980845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013-2015.
    Genus TSE; Bouvier C; Wong KF; Srirajaskanthan R; Rous BA; Talbot DC; Valle JW; Khan M; Pearce N; Elshafie M; Reed NS; Morgan E; Deas A; White C; Huws D; Ramage J
    Br J Cancer; 2019 Nov; 121(11):966-972. PubMed ID: 31649320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and survival of neuroendocrine neoplasms in China with comparison to the United States.
    Zheng R; Zhao H; An L; Zhang S; Chen R; Wang S; Sun K; Zeng H; Wei W; He J
    Chin Med J (Engl); 2023 May; 136(10):1216-1224. PubMed ID: 37022941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
    Yao W; Wang W; Li G
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon.
    Kourie HR; Ghorra C; Rassy M; Kesserouani C; Kattan J
    Asian Pac J Cancer Prev; 2016; 17(5):2679-81. PubMed ID: 27268650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological features of colorectal neuroendocrine neoplasms and prognostic significance of WHO staging system].
    Zhang XH; Lu XL; Wu N; Liu B; Wang FY; Zhang RS; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):191-6. PubMed ID: 23769440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal Neuroendocrine Neoplasms: Areas of Unmet Need.
    Ramage JK; Valle JW; Nieveen van Dijkum EJM; Sundin A; Pascher A; Couvelard A; Kloeppel G; ;
    Neuroendocrinology; 2019; 108(1):45-53. PubMed ID: 30219817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms.
    Leoncini E; Boffetta P; Shafir M; Aleksovska K; Boccia S; Rindi G
    Endocrine; 2017 Nov; 58(2):368-379. PubMed ID: 28303513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in diagnosis and treatment of rectal neuroendocrine neoplasms].
    Wu ZJ; Zhou MY; Zheng ZX; Bi JJ; Wang XS; Feng Q
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):438-444. PubMed ID: 32575937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epidemiological study of neuroendocrine tumours at tertiary hospitals in Bosnia and Herzegovina.
    Konrad Čustović M; Iljazović E; Sadiković A; Karasalihović Z
    Med Glas (Zenica); 2021 Feb; 18(1):77-83. PubMed ID: 33655741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.